We are live on ! Find out more
TNYA icon

Tenaya Therapeutics
TNYA

68 hedge funds and large institutions have $94.7M invested in Tenaya Therapeutics in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 14

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

7% less funds holding

Funds holding: 73 → 68 (-5)

7% less capital invested

Capital invested by funds: $102M → $94.7M (-$7.41M)

11.55% less ownership

Funds ownership: 85.19% → 73.64% (-12%)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

84% less call options, than puts

Call options by funds: $12K | Put options by funds: $76K

Holders
68
Holders Change
-5
Holders Change %
-6.85%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
15
Increased
25
Reduced
14
Closed
20
Calls
$12K
Puts
$76K
Net Calls
-$64K
Net Calls Change
+$81K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$10.9M
2
CC
Casdin Capital
New York
+$6.08M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.76M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$2.53M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.23M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$720K
2
WP
Woodline Partners
California
-$582K
3
BlackRock
BlackRock
New York
-$441K
4
Citigroup
Citigroup
New York
-$393K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$388K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
1
Column Group
California
$18.9M – – –
CC
2
Casdin Capital
New York
$12.2M +$6.08M +2,492,042 +69%
RCM
3
RA Capital Management
Massachusetts
$12.2M +$10.9M +4,465,474 +279%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$8.99M +$5.76M +2,357,950 +112%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$5.69M -$720K -294,822 -9%
RI
6
RTW Investments
New York
$4.94M – – –
BlackRock
7
BlackRock
New York
$4.54M -$441K -180,686 -7%
ROTUOC
8
Regents of the University of California
California
$3.27M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.25M +$1.36M +555,651 +52%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$3.15M – – –
Citadel Advisors
11
Citadel Advisors
Florida
$2.28M +$2.23M +914,733 +421%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$2.08M +$2.53M +1,035,161 New
AI
13
Alphabet Inc
California
$1.84M – – –
EC
14
Euclidean Capital
New York
$1.84M – – –
HMC
15
Harvard Management Company
Massachusetts
$1.35M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$956K +$63.1K +25,836 +6%
SG
17
StepStone Group
California
$929K – – –
State Street
18
State Street
Massachusetts
$858K +$54.5K +22,327 +6%
Blackstone Inc
19
Blackstone Inc
New York
$643K +$780K +319,655 New
TOCUITCONY
20
Trustees of Columbia University in the City of New York
New York
$587K +$712K +291,828 New
Northern Trust
21
Northern Trust
Illinois
$448K -$18.8K -7,707 -3%
Renaissance Technologies
22
Renaissance Technologies
New York
$420K +$105K +42,879 +26%
Walleye Capital
23
Walleye Capital
New York
$410K +$307K +125,704 +161%
TD Asset Management
24
TD Asset Management
Ontario, Canada
$231K +$130K +53,286 +86%
Millennium Management
25
Millennium Management
New York
$226K +$37K +15,168 +16%
1
2 3 4

TNYA Hedge Fund Activity: Q4 2022 in Review

68 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2022, worth a combined $94.7M — down 7.3% from $102M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of TNYA and 15 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 25 added.

The largest buyer was RA Capital Management, adding an estimated $10.9M. The largest seller was Fidelity Investments, cutting an estimated $720K.

  • 68 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2022, down from 73 in Q3 2022.
  • Funds reported $94.7M of Tenaya Therapeutics stock for Q4 2022, down 7.3% quarter-over-quarter.
  • 15 funds opened new Tenaya Therapeutics positions in Q4 2022 and 20 closed out, a net change of -5 holders.
  • The largest Tenaya Therapeutics buyer in Q4 2022 was RA Capital Management, an estimated $10.9M added.
  • The largest Tenaya Therapeutics seller in Q4 2022 was Fidelity Investments, an estimated $720K sold.

Based on aggregated 13F filings for Q4 2022.